Literature DB >> 2158766

Calcium signaling in human platelets.

T J Rink1, S O Sage.   

Abstract

The past three years have seen significant advances in our knowledge and understanding of Ca2+ mobilization in platelets. Some of the data has shown that systems demonstrated in other cell types operate in platelets, while in certain respects platelet studies have provided the lead with new insights and approaches. An increasing body of evidence supports a key role for Ins1,4,5-trisphosphate in mediating internal release, but it has yet to be experimentally demonstrated that this messenger is formed fast enough to account for the observed kinetics of internal release that can reach its maximum rate within 250 msec. There also remains a question as to the presence of an alternative or additional pathway linking at least ADP receptors to internal Ca2+ release. The controversy over the role of pHi in Ca2+ mobilization appears to be resolved; changes in pHi are neither sufficient nor necessary but can modulate the process in some instances. Elevated cAMP and protein kinase C inhibit Ca mobilization, but the sites and mechanisms of action are not worked out. Analysis of receptor-mediated Ca2+ entry by stopped-flow fluorescence has increasingly revealed a complex array of mechanisms, but there is no evidence for voltage-gated Ca2+ entry. There are indications of at least three pathways: a fast entry closely coupled to the ADP receptor; a process that may be generated by a diffusible second messenger, possibly an inositol phosphate; and an entry regulated by the state of filling of the discharged Ca2+ store. A recent advance has been the successful application of the patch-clamp to these tiny cells, with evidence for voltage-gated K+ channels and ADP-stimulated single channels that could be the pathway for the fast phase of ADP-evoked [Ca2+]i elevation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158766     DOI: 10.1146/annurev.ph.52.030190.002243

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  75 in total

1.  trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets.

Authors:  Y Dobrydneva; R L Williams; P F Blackmore
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  Effect of SJAMP on human platelet cytoplasmic Ca2+.

Authors:  T Guo; D Shen; S Song; W Wei
Journal:  J Tongji Med Univ       Date:  1998

Review 3.  Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

4.  Effect of SJAMP on ATP release of platelet.

Authors:  T Guo; D Shen; S Song; W Wei
Journal:  J Tongji Med Univ       Date:  1999

5.  Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.

Authors:  H Dai; J Chen; Q Tao; J Zhu; F Zhang; L Zheng; Y Qiu
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

6.  Dynamics of calcium fluxes in nonexcitable cells: mathematical modeling.

Authors:  Alfonsas Juska
Journal:  J Membr Biol       Date:  2006-09-20       Impact factor: 1.843

7.  Spiking in cytosolic calcium concentration in single fibrinogen-bound fura-2-loaded human platelets.

Authors:  J W Heemskerk; J Hoyland; W T Mason; S O Sage
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

8.  Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

9.  Historical perspective on ADP-induced platelet activation.

Authors:  Marian A Packham; Margaret L Rand
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

10.  Ca(2+)-dependent aggregation of rabbit platelets induced by maitotoxin, a potent marine toxin, isolated from a dinoflagellate.

Authors:  A Watanabe; Y Ishida; H Honda; M Kobayashi; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.